Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
Telix Pharmaceuticals has submitted a new drug application to the United States Food and Drug Administration for TLX007-CDx,
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NEM | Ann: Statement of CDIs on issue - NEM | 24/05/24 | 23 | 5.9K | |||
|
|||||||
NEM | capital gains tax on Newcrest holders | 21/05/24 | 2 | 937 | |||
|
|||||||
NEM | Ann: Dividend/Distribution - NEM | 16/05/24 | 28 | 9K | |||
|
|||||||
NEM | Ann: Form 3 as filed for Francois Hardy | 09/05/24 | 0 | 255 | |||
|
|||||||
NEM | Ann: Form 4 as filed for Peter Wexler | 03/05/24 | 0 | 237 | |||
|
|||||||
NEM | stand alone pre merger | 02/05/24 | 1 | 929 | |||
|
|||||||
NEM | Ann: Form 4 as filed for Susan Story | 01/05/24 | 0 | 156 | |||
|
|||||||
NEM | Ann: Form 4 as filed for Sally-Anne Layman | 01/05/24 | 0 | 216 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |